| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 271 |
| 1 | VEDOLIZUMAB | 258 |
| 2 | INFLIXIMAB | 240 |
| 3 | PREDNISONE | 212 |
| 4 | NIVOLUMAB | 179 |
| 5 | PEMBROLIZUMAB | 176 |
| 6 | DOXYCYCLINE HYCLATE | 135 |
| 7 | DOXYCYCLINE | 126 |
| 8 | AZATHIOPRINE | 117 |
| 9 | METHOTREXATE SODIUM | 113 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | STREPTOZOCIN | 5 | 0.0217 |
| 1 | LINERIXIBAT | 1 | 0.0175 |
| 2 | OLSALAZINE SODIUM | 3 | 0.0152 |
| 3 | MEDICATED HEMORRHOIDAL WIPES | 1 | 0.0115 |
| 4 | INFLIXIMAB-DYYB | 27 | 0.0078 |
| 5 | KETAMINE HYDROCHLORIDE | 35 | 0.0068 |
| 6 | FERRIC DERISOMALTOSE | 9 | 0.0066 |
| 7 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 1 | 0.0062 |
| 8 | CYCLOPENTOLATE HYDROCHLORIDE | 4 | 0.0061 |
| 9 | NALDEMEDINE | 10 | 0.0060 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 340 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 291 |
| 2 | Integrin Receptor Antagonist [EPC] | 258 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 179 |
| 4 | Platinum-based Drug [EPC] | 130 |
| 5 | Tetracycline-class Drug [EPC] | 126 |
| 6 | Purine Antimetabolite [EPC] | 117 |
| 7 | Microtubule Inhibitor [EPC] | 112 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 111 |
| 9 | Bile Acid [EPC] | 100 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bile Acid [EPC] | 100 | 0.0043 |
| 1 | Integrin Receptor Antagonist [EPC] | 258 | 0.0030 |
| 2 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 3 | Bile Acid Sequestrant [EPC] | 23 | 0.0019 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 179 | 0.0018 |
| 5 | Tetracycline-class Drug [EPC] | 126 | 0.0018 |
| 6 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 7 | beta Lactamase Inhibitor [EPC] | 6 | 0.0013 |
| 8 | Purine Antimetabolite [EPC] | 117 | 0.0012 |
| 9 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |